| Figure 8. IL15 promotes the stochastic acquisition of Ly49, CD94,
and NKRP1 molecules by developing NK cells in a similar manner to IL2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 days |
20 days |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| IL2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| IL15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ly49 |
|
|
CD94 |
NKRP1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Immature
NK cells were obtained from E14 thymus and cultured initially for 2 days in
IL4 + PMA. They were then |
| washed,
cultured for 5 or 20 days in medium containing 20nM IL2 or IL15, then stained
with mAb 4D12 that recognizes |
| Ly49E, mAb
18d3 that recognizes CD94, and mAb 10A7 that recognizes NKRP1A and D. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Conclusions |
|
|
|
|
|
|
|
|
|
|
| 1. Developing NK cells gradually acquire the
Ly49 molecules recognized by mAb 4D12 |
|
|
|
|
| 2. By 20 days they show marked heterogeneous
expression of CD94 and of NKRP1A/D. |
|
|
|
|
| 3. The pattern and kinetics of acquisition of
Ly49, CD94, and NKRP1 receptors are essential identical regardless of whether
NK |
| cell
differentiation is driven by IL2 or IL15. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|